Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Asian Journal of Andrology|December 24, 2014
Transcriptome sequencing in prostate cancer identifies inter-tumor heterogeneityJanet Mendonca, Anup Sharma, Sushant Kachhap
Journal of Neuroscience Methods|July 6, 2010
Identification of neuromuscular junctions by correlative confocal and transmission electron microscopyShannon Modla, Janet Mendonca, Kirk J Czymmek, et al.
Cancer Letters|March 13, 2016
C/EBPβ regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome-lysosome fusionDavid J Barakat, Janet Mendonca, Theresa Barberi, et al.
Oncotarget|July 16, 2014
Selective inhibitors of nuclear export (SINE) as novel therapeutics for prostate cancerJanet Mendonca, Anup Sharma, Hae-Soo Kim, et al.
Molecular Oncology|April 4, 2017
The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasionAnup Sharma, Janet Mendonca, James Ying, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 26, 2013
Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitorsMichel D Wissing, Janet Mendonca, Madeleine S Q Kortenhorst, et al.
Cancer Biology & Therapy|February 5, 2013
Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cellsMichel D Wissing, Janet Mendonca, Eunice Kim, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptorRajendra Kumar, Janet Mendonca, Abhishek Shetty, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 28, 2025
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptorRajendra Kumar, Janet Mendonca, Abhishek Shetty, et al.
The Oncologist|January 24, 2013
Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancerEmmanuel S Antonarakis, Elisabeth I Heath, David C Smith, et al.
Pageof 2